Share this video  

VJHemOnc is committed to improving our service to you

ASH 2018 | High economic burden for progressive multiple myeloma: considering costs

The progression of multiple myeloma has been found to pose a significant economic burden. Rafael Fonseca, MD, of the Mayo Clinic, Phoenix, AZ, speaks at the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA, and urges the medical community to consider the long-term, with more expensive treatments potentially giving greater disease control and durable remission further downstream.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter